Advent Has Held Talks to Sell Pharmacy Company Genoa

  • Genoa has more than 400 pharmacies, may be worth $2.5 billion
  • Talks are ongoing and there’s no guarantee of a deal: sources

Drugs

Photographer: Stephen Shaver/Bloomberg
Lock
This article is for subscribers only.

Private-equity firm Advent International has held talks with potential buyers about selling pharmacy company Genoa Healthcare, according to people familiar with the matter.

Genoa, which could be worth about $2.5 billion in a sale, has attracted interest from drugstore chain Walgreens Boots Alliance Inc., among other suitors, said the people, who asked not to be identified because the details aren’t public. Deliberations are ongoing and there’s no guarantee a deal will be reached, according to the people.